Literature DB >> 27439404

The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research.

Amy E Kennedy1, Muin J Khoury2, John P A Ioannidis3, Michelle Brotzman4, Amy Miller4, Crystal Lane5, Gabriel Y Lai1, Scott D Rogers1, Chinonye Harvey1, Joanne W Elena1, Daniela Seminara6.   

Abstract

BACKGROUND: We report on the establishment of a web-based Cancer Epidemiology Descriptive Cohort Database (CEDCD). The CEDCD's goals are to enhance awareness of resources, facilitate interdisciplinary research collaborations, and support existing cohorts for the study of cancer-related outcomes.
METHODS: Comprehensive descriptive data were collected from large cohorts established to study cancer as primary outcome using a newly developed questionnaire. These included an inventory of baseline and follow-up data, biospecimens, genomics, policies, and protocols. Additional descriptive data extracted from publicly available sources were also collected. This information was entered in a searchable and publicly accessible database. We summarized the descriptive data across cohorts and reported the characteristics of this resource.
RESULTS: As of December 2015, the CEDCD includes data from 46 cohorts representing more than 6.5 million individuals (29% ethnic/racial minorities). Overall, 78% of the cohorts have collected blood at least once, 57% at multiple time points, and 46% collected tissue samples. Genotyping has been performed by 67% of the cohorts, while 46% have performed whole-genome or exome sequencing in subsets of enrolled individuals. Information on medical conditions other than cancer has been collected in more than 50% of the cohorts. More than 600,000 incident cancer cases and more than 40,000 prevalent cases are reported, with 24 cancer sites represented.
CONCLUSIONS: The CEDCD assembles detailed descriptive information on a large number of cancer cohorts in a searchable database. IMPACT: Information from the CEDCD may assist the interdisciplinary research community by facilitating identification of well-established population resources and large-scale collaborative and integrative research. Cancer Epidemiol Biomarkers Prev; 25(10); 1392-401. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27439404      PMCID: PMC5480970          DOI: 10.1158/1055-9965.EPI-16-0412

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Authors:  Shannon M Lynch; Alina Vrieling; Jay H Lubin; Peter Kraft; Julie B Mendelsohn; Patricia Hartge; Federico Canzian; Emily Steplowski; Alan A Arslan; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Wei Zheng; Demetrius Albanes; Laufey Amundadottir; Sheila A Bingham; Paolo Boffetta; Marie-Christine Boutron-Ruault; Stephen J Chanock; Sandra Clipp; Robert N Hoover; Kevin Jacobs; Karen C Johnson; Charles Kooperberg; Juhua Luo; Catherine Messina; Domenico Palli; Alpa V Patel; Elio Riboli; Xiao-Ou Shu; Laudina Rodriguez Suarez; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Elissa Tong; Dimitrios Trichopoulos; Jarmo Virtamo; Weimin Ye; Kai Yu; Anne Zeleniuch-Jacquette; H Bas Bueno-de-Mesquita; Rachael Z Stolzenberg-Solomon
Journal:  Am J Epidemiol       Date:  2009-06-26       Impact factor: 4.897

Review 2.  Epidemiology informing clinical practice: from bills of mortality to population laboratories.

Authors:  John D Potter
Journal:  Nat Clin Pract Oncol       Date:  2005-12

3.  Preregistration of epidemiology protocols: a commentary in support.

Authors:  Michael B Bracken
Journal:  Epidemiology       Date:  2011-03       Impact factor: 4.822

4.  A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit.

Authors:  Muin J Khoury; James P Evans
Journal:  JAMA       Date:  2015-06-02       Impact factor: 56.272

5.  Time for a creative transformation of epidemiology in the United States.

Authors:  Michael S Lauer
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

Review 6.  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

Authors:  Maria Schwaederle; Melissa Zhao; J Jack Lee; Alexander M Eggermont; Richard L Schilsky; John Mendelsohn; Vladimir Lazar; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

7.  Multiple loci identified in a genome-wide association study of prostate cancer.

Authors:  Gilles Thomas; Kevin B Jacobs; Meredith Yeager; Peter Kraft; Sholom Wacholder; Nick Orr; Kai Yu; Nilanjan Chatterjee; Robert Welch; Amy Hutchinson; Andrew Crenshaw; Geraldine Cancel-Tassin; Brian J Staats; Zhaoming Wang; Jesus Gonzalez-Bosquet; Jun Fang; Xiang Deng; Sonja I Berndt; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; Richard B Hayes; David J Hunter; Stephen J Chanock
Journal:  Nat Genet       Date:  2008-02-10       Impact factor: 38.330

8.  Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?

Authors:  Mark Lawler; Richard Sullivan
Journal:  Public Health Genomics       Date:  2015-11-11       Impact factor: 2.000

9.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors:  Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 11.816

10.  Genetic variation in the HSD17B1 gene and risk of prostate cancer.

Authors:  Peter Kraft; Paul Pharoah; Stephen J Chanock; Demetrius Albanes; Laurence N Kolonel; Richard B Hayes; David Altshuler; Gerald Andriole; Christine Berg; Heiner Boeing; Noel P Burtt; Bas Bueno-de-Mesquita; Eugenia E Calle; Howard Cann; Federico Canzian; Yen-Ching Chen; David E Crawford; Alison M Dunning; Heather S Feigelson; Matthew L Freedman; John M Gaziano; Ed Giovannucci; Carlos Alberto Gonzalez; Christopher A Haiman; Goran Hallmans; Brian E Henderson; Joel N Hirschhorn; David J Hunter; Rudolf Kaaks; Timothy Key; Loic Le Marchand; Jing Ma; Kim Overvad; Domenico Palli; Malcolm C Pike; Elio Riboli; Carmen Rodriguez; Wendy V Setiawan; Meir J Stampfer; Daniel O Stram; Gilles Thomas; Michael J Thun; Ruth Travis; Antonia Trichopoulou; Jarmo Virtamo; Sholom Wacholder
Journal:  PLoS Genet       Date:  2005-11-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.